Cell Source Inc. (OTC: CLCS) Stock In Focus After Major Potential Breakthrough
Immune tolerance management company Cell Source Inc. (OTC: CLCS) could be on the radars of investors this morning. Yesterday the company hit the news wires after it provided a key update with regards to the presentation of preclinical data. Significant Breakthrough The company revealed yesterday that it had made a presentation of strong preclinical data at the 2024 American Society of Hematology (ASH) Annual Meeting. In the news release, Cell…